JOINT WEBINAR WITH LABCORP DRUG DEVELOPMENT
In this webinar we will discuss the advantages of a 3D culture approach over the traditional methods, with particular emphasis on the importance of tumor microenvironment and tissue-relevant extracellular matrix (ECM) in obtaining accurate drug response data. We will highlight the unique advantages zPREDICTA’s tumor-specific 3D culture platform where both cellular and extracellular components of tumor microenvironment are reconstructed in vitro. Clinical study data demonstrate high correlation between drug efficacy measured in our platform and clinical response. The ability of zPREDICTA’s platform to reliably predict clinical outcomes offers superior compound attrition management, empowering researchers to exclude ineffective compounds while selecting agents with a high probability of success in the clinic.